Printer Friendly
The Free Library
14,550,678 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zila Appoints General Manager to Nutraceutical Division.


PHOENIX -- Zila, Inc.'s (Nasdaq: ZILA) wholly-owned subsidiary, Zila Nutraceuticals, Inc., maker of Ester-C(R) and Ester-E(R), has appointed industry veteran Bernie Landes as its Vice President and General Manager.

"Bernie's unique background and experience in the nutraceutical market is ideal for leading the continued growth and evolution of our Ester(TM) branded products as we position the business to quickly achieve our larger strategic objectives for the Company," said Douglas Burkett, Ph.D., Chairman, Chief Executive Officer and President of Zila, Inc. "As we diversify and grow our customer base both domestically and internationally, Bernie is the perfect leader to launch Zila Nutraceuticals into this new phase of growth."

Mr. Landes recently served as President of Nutritional Products Group providing services to the dietary supplement, nutraceutical, personal care, environmental, functional and traditional food industries. His other professional accomplishments include serving as Chairman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Paracelsian, Inc., General Manager for Alacer Corp., and Director of Marketing, Strategic Planning, New Product Planning, Regulatory Affairs and Nutrition Science for Health Valley Foods. Mr. Landes has a Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science
BS, SB

bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies
 in Business Administration and an MBA MBA
abbr.
Master of Business Administration

Noun 1. MBA - a master's degree in business
Master in Business, Master in Business Administration
 in Marketing/Consumer Psychology, both from the University of Delaware [3] The student body at the University of Delaware is largely an undergraduate population. Delaware students have a great deal of access to work and internship opportunities. .

"Ester-C is the industry's most successfully branded vitamin C vitamin C
 or ascorbic acid

Water-soluble organic compound important in animal metabolism. Most animals produce it in their bodies, but humans, other primates, and guinea pigs need it in the diet to prevent scurvy.
 product. Extending the well-known Ester brand into new delivery forms and categories which are almost limitless, is an exciting opportunity," said Mr. Landes. "When I think of the market potential of combining new product opportunities with entry into some of the world's largest supplement markets, I envision tremendous growth of marketshare for Zila."

About Ester-C(R)

Ester-C is an advanced form of vitamin C that is pH neutral, providing a form that is easily tolerated by the body. During the patented process of producing Ester-C, the ascorbic acid undergoes changes similar to those that occur in the body, which results in vitamin C metabolites Metabolites
Substances produced by metabolism or by a metabolic process.

Mentioned in: Interactions
. It is the only vitamin C that contains these metabolites, which help it work differently than regular vitamin C. Ester-C has also been clinically proven to remain active in the immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 for 24 hours Adv. 1. for 24 hours - without stopping; "she worked around the clock"
around the clock, round the clock
.

About Ester-E(R)

Ester-E is an advanced form of vitamin E vitamin E
 or tocopherol

Fat-soluble organic compound found principally in certain plant oils and leaves of green vegetables. Vitamin E acts as an antioxidant in body tissues and may prolong life by slowing oxidative destruction of membranes.
 containing d-alpha tocopheryl phosphates (or "TP" for short). Until recently, scientists were unaware of this important source of vitamin E in the body. Research suggests that the human body may convert other forms of vitamin E into TP in order to protect the vitamin's antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene  strength until the body is ready to use it. Scientists are now able to replicate this natural form of vitamin E by joining a phosphate molecule to natural vitamin E in a patented process, preserving vitamin E's natural health benefits until the body is ready to use it. Therefore, Ester-E is protected until it is needed, rather than being used up prematurely.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Visit www.Ester-E.com or www.Ester-C.com for more information about the "Ester" line of premium products.

About Zila, Inc.

Zila, Inc., headquartered in Phoenix, is an innovator in preventative healthcare technologies and products, focusing on enhanced body defense and the detection of pre-disease states. Zila has three business units:

--Zila Pharmaceuticals, marketer of products to promote oral health and prevent oral disease, including ViziLite(R) Plus oral examination kits and Peridex(R) prescription periodontal periodontal /peri·odon·tal/ (per?e-o-don´t'l)
1. pertaining to the periodontal ligament or periodontium.

2. near or around a tooth.


per·i·o·don·tal
adj.
1.
 rinse.

--Zila Biotechnology, a research, development and licensing business specializing in pre-cancer/cancer detection through its patented Zila(R) Tolonium Chloride tolonium chloride

see toluidine blue.
 and OraTest(R) technologies.

--Zila Nutraceuticals, manufacturer and marketer of Ester-C(R) and Ester-E(R), branded, highly effective forms of Advanced Protection vitamins C and E.

For more information about Zila, visit www.zila.com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on Zila's expectations or forecasts of future events, can be affected by inaccurate assumptions and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements contained herein. A wide variety of factors could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There can be no assurance that the forward-looking statements contained in this press release will, in fact, transpire or prove to be accurate. For a more detailed description of these and other cautionary factors that may affect Zila's future results, please refer to Zila's Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for its fiscal year ended July 31, 2005.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 5, 2006
Words:777
Previous Article:AMD Opteron(TM) Processor One of Sun Microsystems' Core Offerings for Next Generation Telecommunications Platform.
Next Article:Grupo TMM Announces Dates for First Quarter 2006 Earnings Release and Conference Call.
Topics:



Related Articles
Antimicrobial hand wash.(Brief Article)
Zila Appoints Dr. Douglas D. Burkett President & CEO; Joseph Hines Continues as Chairman.
Zila's Innovative Swab Technologies Unit Receives $2.5 Million Contract.
New Board Members Elected At Zila Shareholders Meeting.
Pharmaceutical. (Newsmakers).(Health Sciences Group Inc. names Joseph Hines to advisory board)(Brief Article)
Zila Strengthens Biotechnology Business; Reports on Sufficient OraTest Funding, Adds Experts & Expands Objectives.
Zila Receives $20 Million Settlement Payment; Strong Financial Position Will Support Aggressive Growth Strategy.
Zila Expands International Market of Ester-C(R) into Korea and Taiwan; Lohaspia, Inc. Signs Distributor Agreement.
Zila Files Preliminary Proxy Statement.
Zila Appoints David R. Bethune as Chairman of Board of Directors.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles